Biomarkers in Medicine
Overview
Biomarkers in Medicine is a peer-reviewed journal that focuses on the discovery, validation, and clinical application of biomarkers in various medical fields. It provides a platform for researchers and clinicians to share advancements in biomarker research, their potential diagnostic and prognostic applications, and their role in personalized medicine. The journal covers a wide range of topics, including biomarker identification, validation techniques, and their impact on disease diagnosis, treatment response, and patient outcomes.
Details
Details
Abbr.
Biomark Med
Start
2007
End
Continuing
Frequency
Eighteen issues a year, 2019-
p-ISSN
1752-0363
e-ISSN
1752-0371
Country
United Kingdom
Language
English
Specialties
General Medicine
Biochemistry
Biochemistry
Metrics
Metrics
h-index / Ranks: 6577
56
SJR / Ranks: 9193
481
CiteScore / Ranks: 7421
3.60
JIF / Ranks: 4835
2.2
Recent Articles
1.
Yilmaz Y, Ozercan M, Ancin B, Dikmen Z, Caglar Tuncali M, Tuncel M, et al.
Biomark Med
. 2025 Mar;
:187-194.
PMID: 40083263
Aim: To investigate the relationship between serum human epididymis protein 4 (HE4) levels and metabolic parameters of positron emission tomography (PET) imaging in patients with lung cancer. Methods: Sixty non-small...
2.
Huang Y, Wang J, Chen S, Dai Z, Chen X, Li X, et al.
Biomark Med
. 2025 Mar;
19(5):177-186.
PMID: 40071342
Aims: This research aims to elucidate the association between red cell distribution width (RDW) and the severity of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Patients & Methods: This...
3.
Luo B, Zhang K, Jiang Z, Xie Y, Wu Y, Wang R, et al.
Biomark Med
. 2025 Mar;
:1-8.
PMID: 40038869
Objective: To investigate the prognostic potential of preoperative blood neutrophil to lymphocyte ratio (NLR), hematocrit (HCT) and Fibrinogen (FIB) level in patients with colorectal cancer (CRC). Methods: The data of...
4.
Feng C, Fan Y, Gao H, Zhang B, Lu X
Biomark Med
. 2025 Mar;
19(6):205-213.
PMID: 40035348
Aims: This study mainly explored the regulatory role and mechanism of MCCC2 in GBM. Methods: This study verified the expression in clinical samples and GBM cell lines. CCK-8 and cell...
5.
Hancioglu E, Ozcan S, Donmez E, Terzioglu C, Kirankaya A, Tenekecigil A, et al.
Biomark Med
. 2025 Mar;
19(6):187-195.
PMID: 40033847
Objective: Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young individuals. Lumican, is an indicator of fibrosis. We aimed to evaluate the relation between serum Lumican...
6.
Ulusoy B, Armagan B, Erdogan E, Maras Y, Dogan I, Orhan K, et al.
Biomark Med
. 2025 Mar;
19(5):149-156.
PMID: 40024670
Objective: This study aims to investigate discriminatory ability of the Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Neutrophil Percentage-to-Albumin Ratio (NPAR), in differentiating Behçet's Syndrome (BS) organ...
7.
Golestan A, Zareinejad M, Ramezani A
Biomark Med
. 2025 Feb;
19(6):223-238.
PMID: 40015744
Hematological malignancies present substantial challenges in clinical practice due to their heterogeneity and complex biological profiles. In these diseases, biomarkers - measurable indicators of biological states - are indispensable for...
8.
Eyiol H, Eyiol A, Sahin A
Biomark Med
. 2025 Feb;
19(6):197-204.
PMID: 40013601
Aim: This study evaluated the Hemoglobin to Red Cell Distribution Width Ratio (HRR) and Red Cell Distribution Width to Albumin Ratio (RAR) in acute pericarditis patients, exploring associations with clinical...
9.
Liu H, Li S, Zhang F, He W, Gou X, Zhang X, et al.
Biomark Med
. 2025 Feb;
19(6):215-222.
PMID: 40010749
Purpose: This study aimed to determine the prognostic value of preoperative Neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic renal cell carcinoma (mRCC) undergoing cytoreductive nephrectomy (CN). Methods: We retrospectively investigated...
10.
Ilis D, Arslan A, Artac I, Karakayali M, Omar T, Hamideyin S, et al.
Biomark Med
. 2025 Feb;
19(5):139-147.
PMID: 40008439
Aims: We aimed to investigate the association between the HALP score and in-hospital mortality in patients with non-ST segment myocardial infarction (NSTEMI). Materials And Methods: In this retrospective study participants...